Health Condition 1: C509- Malignant neoplasm of breast of unspecified site
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Age group in between 30 and 80 years, diagnosed with stage I and II breast carcinoma. 2. ASA I and II patients. 3. In patients whom consented for the procedure. 4. Patients with normal coagulation profile.
Exclusion criteria
Exclusion criteria: 1. Patient with chest wall / spine deformities. 2. Pregnancy. 3. Change in the procedure planed ; that is if initially the patient was planed for MRM later changed to more invasive procedure on table.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Compare the efficacy of levobupivacaine 0.125% adjuvant (dexmedetomidine) with levobupivacaine 0.25% adjuvant (dexmedetomidine) in an ultrasound-guided PEC Block as analgesia during a 24-hr period after MRM.Timepoint: 24 Hours | — |
Secondary
| Measure | Time frame |
|---|---|
| To compare the requirement for rescue analgesia in both groupsTimepoint: 24 hours;Whether the PEC Block reduced the amount of analgesia used postoperatively.Timepoint: 24 hours | — |
Countries
India
Contacts
Junior resident at the department of anesthesiology, Indira Gandhi Medical College, Shimla.